Icad Inc (ICAD) concluded trading on Wednesday at a closing price of $3.07, with 21.2 million shares of worth about $65.08 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 100.65% during that period and on April 16, 2025 the price saw a gain of about 59.07%. Currently the company’s common shares owned by public are about 26.35M shares, out of which, 25.78M shares are available for trading.
Stock saw a price change of 74.43% in past 5 days and over the past one month there was a price change of 32.33%. Year-to-date (YTD), ICAD shares are showing a performance of 67.76% which increased to 88.34% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.18 but also hit the highest price of $3.78 during that period. The average intraday trading volume for Icad Inc shares is 505.75K. The stock is currently trading 52.21% above its 20-day simple moving average (SMA20), while that difference is up 25.95% for SMA50 and it goes to 61.33% higher than SMA200.
Icad Inc (NASDAQ: ICAD) currently have 26.35M outstanding shares and institutions hold larger chunk of about 19.29% of that.
The stock has a current market capitalization of $84.02M and its 3Y-monthly beta is at 1.46. It has posted earnings per share of -$0.21 in the same period. It has Quick Ratio of 3.40 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ICAD, volatility over the week remained 9.38% while standing at 9.03% over the month.
Stock’s fiscal year EPS is expected to drop by -10.00% while it is estimated to increase by 45.45% in next year. EPS is likely to grow at an annualized rate of 70.76% for next 5-years, compared to annual growth of 21.98% made by the stock over the past 5-years.
Coverage by Guggenheim stated Icad Inc (ICAD) stock as a Buy in their note to investors on April 22, 2021, suggesting a price target of $24 for the stock. On March 23, 2021, BTIG Research Initiated their recommendations, while on February 26, 2021, Oppenheimer Initiated their ratings for the stock with a price target of $27. Stock get an Overweight rating from Cantor Fitzgerald on January 29, 2021.
